UB Paderborn / Katalog / Suche / in CDI

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling

Annals of oncology, 2017-09, Vol.28 (9), p.2160-2168

2017

Link zum Volltext

Verfügbarkeit prüfen

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment

European journal of surgical oncology, 2016-12, Vol.42 (12), p.1873-1880

2016

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii171-viii172

2018

Link zum Volltext

Verfügbarkeit prüfen

P-160Impact of KRAS mutation on patterns of metastasis in a series of colorectal cancer patients

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii47-ii47

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

Colorectal disease, 2013-04, Vol.15 (4), p.414-422

2013

Link zum Volltext

Verfügbarkeit prüfen

84P Next-generation sequencing (NGS) in metastatic colorectal cancer (mCRC): Clinical utility in daily practice in a comprehensive cancer centre

Annals of oncology, 2024-06, Vol.35, p.S41-S42

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer

Cancers, 2023-06, Vol.15 (13), p.3301

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of galectin 3 and galectin 1 in colorectal cancer progression

Gastroenterology (New York, N.Y. 1943), 1997-12, Vol.113 (6), p.1906-1915

1997

Link zum Volltext

Verfügbarkeit prüfen

478P TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

Annals of oncology, 2021-09, Vol.32, p.S570-S570

2021

Link zum Volltext

Verfügbarkeit prüfen

P-195 SPRY2 and response to FOLFOX/CAPOX in metastatic KRAS mutated colorectal cancer

Annals of oncology, 2015-06, Vol.26, p.iv56

2015

Link zum Volltext

Verfügbarkeit prüfen

P-160 Impact of KRAS mutation on patterns of metastasis in a series of colorectal cancer patients

Annals of oncology, 2016-06, Vol.27, p.ii47

2016

Link zum Volltext

Verfügbarkeit prüfen

Extended genotyping of RAS/BRAF for improved selection of metastatic CRC patients to anti-EGFR therapy: Comparison of three platforms

Annals of oncology, 2016-10, Vol.27, p.vi16-vi16

2016

Link zum Volltext

Verfügbarkeit prüfen

O-012 Nanofluidic digital PCR and extended genotyping of RAS, BRAF and PI3KCA for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies

Annals of oncology, 2015-06, Vol.26, p.iv112

2015

Link zum Volltext

Verfügbarkeit prüfen

GALECTIN-3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON-NEOPLASTIC THYROID TISSUE

The Journal of pathology, 1997-01, Vol.181 (1), p.80-86

1997

Link zum Volltext

Verfügbarkeit prüfen

OVEREXPRESSION OF THE 67-kD LAMININ RECEPTOR CORRELATES WITH TUMOUR PROGRESSION IN HUMAN COLORECTAL CARCINOMA

The Journal of pathology, 1996-08, Vol.179 (4), p.376-380

1996

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Mechanism of Action Study of Intra-Tumoural (It) or Intravenous (Iv) Administration of Enadenotucirev, an Oncolytic Ad11/Ad3 Chimeric Group B Adenovirus in Colon Cancer Patients Undergoing Resection of Primary Tumour

Annals of oncology, 2014-09, Vol.25, p.iv368

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis

Neoplasia (New York, N.Y.), 2011-10, Vol.13 (10)

2011

Link zum Volltext

Verfügbarkeit prüfen

512PKRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Colonoscopic findings from a pilot screening study for colorectal cancer in Catalonia

Revista española de enfermedades digestivas, 2008-06, Vol.100 (6), p.343-348

2008

Link zum Volltext

Verfügbarkeit prüfen

Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): Clinical audit as a basis for action

European journal of surgical oncology, 2011-04, Vol.37 (4), p.325-333

2011

Link zum Volltext

Verfügbarkeit prüfen

Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine‐needle aspiration cytology

Cancer, 1999-08, Vol.87 (4), p.231-237

1999

Link zum Volltext

Verfügbarkeit prüfen

227PPROGNOSIS OF PHOSPHORYLATED-INSULIN GROWTH FACTOR RECEPTOR (P-IGF-1R) AND METALLOPROTEINASE-3 (MMP3) EXPRESSION IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PATIENTS TREATED WITH IMATINIB. A GEIS STUDY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv76-iv77

2014

Link zum Volltext

Verfügbarkeit prüfen

1068PA PHASE 1 MECHANISM OF ACTION STUDY OF INTRA-TUMOURAL (IT) OR INTRAVENOUS (IV) ADMINISTRATION OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS IN COLON CANCER PATIENTS UNDERGOING RESECTION OF PRIMARY TUMOUR

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv368-iv368

2014

Link zum Volltext

Verfügbarkeit prüfen

Alveolar soft part sarcoma: The role of prognostic markers

Annals of diagnostic pathology, 2000-06, Vol.4 (3), p.135-142

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment

KRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients

P-160Impact of KRAS mutation on patterns of metastasis in a series of colorectal cancer patients

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

84P Next-generation sequencing (NGS) in metastatic colorectal cancer (mCRC): Clinical utility in daily practice in a comprehensive cancer centre

Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer

Differential expression of galectin 3 and galectin 1 in colorectal cancer progression

478P TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment

P-195 SPRY2 and response to FOLFOX/CAPOX in metastatic KRAS mutated colorectal cancer

P-160 Impact of KRAS mutation on patterns of metastasis in a series of colorectal cancer patients

Extended genotyping of RAS/BRAF for improved selection of metastatic CRC patients to anti-EGFR therapy: Comparison of three platforms

O-012 Nanofluidic digital PCR and extended genotyping of RAS, BRAF and PI3KCA for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies

GALECTIN-3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON-NEOPLASTIC THYROID TISSUE

Prognosis of Phosphorylated-Insulin Growth Factor Receptor (P-Igf-1R) and Metalloproteinase-3 (Mmp3) Expression in Advanced Gastrointestinal Stromal Tumors (Gist) Patients Treated with Imatinib. a Geis Study

OVEREXPRESSION OF THE 67-kD LAMININ RECEPTOR CORRELATES WITH TUMOUR PROGRESSION IN HUMAN COLORECTAL CARCINOMA

A Phase 1 Mechanism of Action Study of Intra-Tumoural (It) or Intravenous (Iv) Administration of Enadenotucirev, an Oncolytic Ad11/Ad3 Chimeric Group B Adenovirus in Colon Cancer Patients Undergoing Resection of Primary Tumour

Hepatic Carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis

512PKRAS mutations as a prognostic factor after metastasectomy in colorectal cancer patients

Colonoscopic findings from a pilot screening study for colorectal cancer in Catalonia

Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): Clinical audit as a basis for action

Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine‐needle aspiration cytology

227PPROGNOSIS OF PHOSPHORYLATED-INSULIN GROWTH FACTOR RECEPTOR (P-IGF-1R) AND METALLOPROTEINASE-3 (MMP3) EXPRESSION IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PATIENTS TREATED WITH IMATINIB. A GEIS STUDY

1068PA PHASE 1 MECHANISM OF ACTION STUDY OF INTRA-TUMOURAL (IT) OR INTRAVENOUS (IV) ADMINISTRATION OF ENADENOTUCIREV, AN ONCOLYTIC AD11/AD3 CHIMERIC GROUP B ADENOVIRUS IN COLON CANCER PATIENTS UNDERGOING RESECTION OF PRIMARY TUMOUR

Alveolar soft part sarcoma: The role of prognostic markers

Suchergebnisse filtern